Lanopepden
Modify Date: 2025-08-25 18:35:23
Lanopepden structure
|
Common Name | Lanopepden | ||
|---|---|---|---|---|
| CAS Number | 1152107-25-9 | Molecular Weight | 479.54800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H34FN7O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LanopepdenLanopepden (GSK 1322322) is a peptide deformylase inhibitor active against Staphylococcus aureus strains with MICs of 1 and 1 mg/L for ATCC 29213 and ATCC 25923 strain, respectively[1]. |
| Name | N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide |
|---|---|
| Synonym | More Synonyms |
| Description | Lanopepden (GSK 1322322) is a peptide deformylase inhibitor active against Staphylococcus aureus strains with MICs of 1 and 1 mg/L for ATCC 29213 and ATCC 25923 strain, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H34FN7O4 |
|---|---|
| Molecular Weight | 479.54800 |
| Exact Mass | 479.26600 |
| PSA | 126.65000 |
| LogP | 2.48420 |
| Storage condition | 2-8℃ |
| gsk-322 |
| unii-12m6kfd07e |